FutureMed Synthesis Videos 2012

Marty Kohn, MD: IBM’s Watson Supercomputer

Martin Kohn, MD, MS, Chief Medical Scientist, Care Delivery Systems, IBM Research, talks about Watson, the IBM supercomputer capable of natural language processing, and the role machines like it will play in helping practitioners manage the ever-increasing volume of medical data available.

Russ Altman MD, PhD: Drug & Data Integration

Russ Altman, MD, PhD, Professor & Chair, Bioengineering, Stanford University School of Medicine, discusses the therapeutic advantages to be gained from integrating molecular, cellular, EMR and population data to understand how drugs work, alone and in combination.

Anne DeGheest, Managing Director & Founder, HealthTech CAPITAL, offers advice to entrepreneurs developing solutions for medical workflow management and patient engagement.

Ajay Verma, MD, PhD, VP, Neurodegeneration & Translational Neurology, Biogen Idec, suggests that we carry a biologic blueprint for death that may include “grim reaper” mechanisms.

Journalist David Ewing Duncan, discusses his personal experiences with the technologies of personalized medicine, and touches on the implications of genomics, proteomics, metabolomics and microbiomics.

Lucky Gunasekara, CIO, Global Viral Forecasting Initiative, talks about the challenges of moving medical education away from a linear model and preparing student to solve, non-linear, exponential problems.

Paul Grundy, Global Director, Healthcare Transformation, IBM, discusses the movement of medical practice from an “episode of care” model to the management of populations, and the emergence of the patient-centered medical home.

Christopher deCharms, Founder & CEO, Omneuron, explains that recent advances allow the “reading” of thoughts directly from the brain via functional MRI and other technologies

Alan Greene, Founder, DrGreene.com, talks about the ways that what children eat literally shapes them – today and throughout their lives.

Randy Scott, PhD, Executive Chairman, Genomic Health, talks about advances in genome-based testing and understanding of cancer.

David Hale, Project Manager of  Pillbox, at the National Library of Medicine, describes the Pillbox initiative, which leverages large, open, but unwieldy drug information databases to facilitate rapid, easy development of drug IT applications.

Amir Belson, MD, CTO, Neoguide Systems, discusses his invention of the Neoguide colonoscope.

Mobile phones and diagnostic devices are merging to provide quality 
clinical measurements from anywhere. David Albert, MD, Founder & Chief 
Medical Officer, AliveCor, demonstrates the AliveCor 
ECG, an iPhone accessory that will allow both physicians and patients to 
capture and transmit clinical quality heart ECG data using their smart 
phones.

Aubrey de Grey, MA, PhD, Chief 
Science Officer and Founder, SENS Foundation, offers 
a definition of aging that refocuses the question of whether or not aging 
is an inevitable process.

Sheri Fink, MD, PhD, Pulitzer Prize winning journalist with ProPublica, and Senior Fellow, New 
America Foundation discusses the role that 
technology can, and should, play in organizing and managing humanitarian 
aid efforts.

Philip Low, PhD, Founder, Chairman & 
CEO, NeuroVigil , talks about a pioneering new 
paradigm for non-invasive and portable brain scanning using a single 
channel electrode to examine brain function and structures.

Director, Virtual 
Human Interaction Lab, Stanford University, 
talks about the power of virtual reality technology to effect behavioral 
change, especially in the challenging area of lifestyle modification.